Final FY2026 numbers: 315,825 utility grants, continuing applications at 26% of grants, US-origin share at 39%, published applications down 6%, and cross-border inventor teams on a record 10.7% of ...
Crocs asks the Supreme Court whether one ITC determination can start two appeal clocks after the Federal Circuit dismissed ...
Professor John Duffy (UVA) appears to be in line to take over as USPTO General Counsel. GC is the Director’s principal legal advisor and runs an office of about 130 lawyers that include the Office of ...
The "optimization" claims of US8842761 and US10693700 are ineligible under § 101; The "constellation" claims of US11019509 and US11018922 are eligible; The infringement verdict stands (denial of JMOL ...
Zilkr Cloud Technologies, LLC v. Cisco Systems, Inc., No. 2025-1207 (Fed. Cir. Aug. 26, 2026) (nonprecedential). Although the PTAB's claim construction in this case might have been "reasonable," the ...
Over the past twelve months, the Supreme Court denied certiorari in 36 cases raising patent questions. It granted one, Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc., 608 U.S. ___ (2026), which ...
With the USPTO's recent brief, In re Ablynx N.V., No. 2026-1333 (Fed. Cir.) is now teed up for the Federal Circuit to decide the nationwide policy on obviousness-type double patenting. The case ...
The USPTO’s “settled expectations” policy now has a second challenger at the Supreme Court. On July 24, 2026, Kahoot! AS filed a petition for certiorari (docket number pending) asking the Court to ...
The Supreme Court has been asked to decide whether an act of Congress can reallocate ownership of foreign copyrights. In BMG Rights Management (US) LLC v. Vetter, No. 25-1391, four music publishing ...
As the 2025-2026 term ends, the Supreme Court has agreed to decide whether the strength of a trademark is a question of fact or a question of law. The Court granted certiorari in RiseandShine Corp. v.
A seeming typo in Enanta’s provisional application left the resulting patent invalid. In Enanta Pharmaceuticals, Inc. v. Pfizer, Inc., No. 2025-1427 (Fed. Cir. June 23, 2026), the Federal Circuit ...